Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 20;18(4):875.
doi: 10.3390/ijms18040875.

Aneurysm-Specific miR-221 and miR-146a Participates in Human Thoracic and Abdominal Aortic Aneurysms

Affiliations

Aneurysm-Specific miR-221 and miR-146a Participates in Human Thoracic and Abdominal Aortic Aneurysms

Premakumari Venkatesh et al. Int J Mol Sci. .

Abstract

Altered microRNA expression is implicated in cardiovascular diseases. Our objective was to determine microRNA signatures in thoracic aortic aneurysms (TAAs) and abdominal aortic aneurysms (AAAs) compared with control non-aneurysmal aortic specimens. We evaluated the expression of fifteen selected microRNA in human TAA and AAA operative specimens compared to controls. We observed significant upregulation of miR-221 and downregulation of miR-1 and -133 in TAA specimens. In contrast, upregulation of miR-146a and downregulation of miR-145 and -331-3p were found only for AAA specimens. Upregulation of miR-126 and -486-5p and downregulation of miR-30c-2*, -155, and -204 were observed in specimens of TAAs and AAAs. The data reveal microRNA expression signatures unique to aneurysm location and common to both thoracic and abdominal pathologies. Thus, changes in miR-1, -29a, -133a, and -221 are involved in TAAs and miR-145, -146, and -331-3p impact AAAs. This work validates prior studies on microRNA expression in aneurysmal diseases.

Keywords: abdominal aortic aneurysm; microRNA; thoracic aortic aneurysm.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Alterations in microRNA profiles of miR-1 (a), miR-21 (b), miR-29a (c), miR-30c-2* (d), miR-124 (e), and mir-126 (f) by qRT-PCR. Expression levels in TAA (n = 11) and AAA (n = 3) as compared with non-aneurysmal control aorta (n = 8). The relative amount of each miRNA was normalized to small nucleolar RNA (RNU44). Statistically significant differences: * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 2
Figure 2
Alteration in microRNA profiles of miR-133a (a), miR-145 (b), miR-146a (c), miR-155 (d), miR-204 (e), and miR-221 (f) by qRT-PCR. Expression levels in TAA (n = 11) and AAA (n = 3) as compared with non-aneurysmal control aorta (n = 8). The relative amount of each miRNA was normalized to RNU44. Statistically significant differences: * p < 0.05, ** p < 0.01.
Figure 3
Figure 3
Alteration in microRNA profiles of miR-222 (a), miR-331-3p (b), and miR-486-5p (c) by qRT-PCR. Expression levels in TAA (n = 11) and AAA (n = 3) as compared with non-aneurysmal control aorta (n = 8). The relative amount of each miRNA was normalized to RNU44. Statistically significant differences: * p < 0.05.
Figure 4
Figure 4
Heat map (Human miRNA microarray) depicting 45 differentially expressed miRNAs in TAA. Differentially expressed miRNAs (p < 0.05 and absolute value (fold change) > 1.5) in TAA specimens as compared with non-aneurysmal control aorta is shown. Arrows indicate the miRNAs whose expression was similar in qRT-PCR analysis. TAA (n = 5) and normal (n = 3).
Figure 5
Figure 5
Volcano map demonstrating differences in miRNA expression levels in TAA by microarray. The log-fold change is plotted against the log odds of differential expression. The miRNAs with significant differences in expression levels between the TAA (n = 5) and control (n = 3) groups (p < 0.05) after Benjamini-Hochberg correction are indicated.
Figure 6
Figure 6
Dominant cardiovascular miRNAs patterns observed in TAA and AAA.

Similar articles

Cited by

References

    1. Meszaros I., Morocz J., Szlavi J., Schmidt J., Tornoci L., Nagy L., Szep L. Epidemiology and clinicopathology of aortic dissection. Chest. 2000;117:1271–1278. doi: 10.1378/chest.117.5.1271. - DOI - PubMed
    1. Bozeman M.C., Ross C.B. Intra-abdominal hypertension and abdominal compartment syndrome in association with ruptured abdominal aortic aneurysm in the endovascular era: Vigilance remains critical. Crit. Care Res. Pract. 2012;2012:151650. doi: 10.1155/2012/151650. - DOI - PMC - PubMed
    1. Ye Z., Bailey K.R., Austin E., Kullo I.J. Family history of atherosclerotic vascular disease is associated with the presence of abdominal aortic aneurysm. Vasc. Med. 2016;21:41–46. doi: 10.1177/1358863X15611758. - DOI - PMC - PubMed
    1. Peshkova I.O., Schaefer G., Koltsova E.K. Atherosclerosis and aortic aneurysm: Is inflammation a common denominator? FEBS J. 2016;283 doi: 10.1111/febs.13634. - DOI - PubMed
    1. Abdulkareem N., Smelt J., Jahangiri M. Bicuspid aortic valve aortopathy: Genetics, pathophysiology and medical therapy. Interact. Cardiovasc. Thorac. Surg. 2013;17:554–559. doi: 10.1093/icvts/ivt196. - DOI - PMC - PubMed

LinkOut - more resources